MEA Microbiome Sequencing Services Market

MEA Microbiome Sequencing Services Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa Microbiome sequencing services market size is valued at USD 60.34 Million in 2023. It is expected to grow at a CAGR of 19.23% to reach USD 145.40 Million by 2028 during the forecast period 2023 to 2028.

An increase in the vast expenditures in microbiome research with the growing demand for Next Generation Sequencing services is driving the MEA Microbiome sequencing services market. 

The expanding application area of microbiome sequencing is driving market development by applying different identification approaches and increasing the NGS in the resolution of bacterial species identification.

The sequencing capabilities of Next Generation Sequencing technology have undergone a paradigm change. This knowledge has been widely utilized in biological studies to yield meaningful and surprising insights into molecular cell biology.

The target identification and single nucleotide polymorphisms are the essential phases in pharmaceutical firms' drug development process and are widely used for analyzing purposes. The growing need for microbiome sequencing research and applications in cancer is encouraging the government and private organizations to invest. 

 Furthermore, the increase in the demand for the services has grown continuously by contributing to the regional incidence of colorectal cancer. Therefore, according to the International Agency for Research on Cancer's 2019 report, the incidence of colon cancer is predicted to rise from over 1.1 million in 2019 to more than 1.5 million by 2030. As a result, all of these variables play a role in total market growth. And, by 2030, worldwide, more than 2.2 million new cases with 1.1 million deaths are estimated to increase the burden of colorectal cancer.

Therefore, as a result, the growing demand for NGS services in various biological domains is propelling the market.

Moreover, in the recent period, several firms in the region are focusing on new exome sequencing and RNA sequencing applications in specialized market sectors, which is expected to provide lucrative growth opportunities for the new market entrants. 

However, the increase in the high costs of the services and the lack of skilled and proficient individuals for the analysis of Next- Generation Sequencing are limiting the market growth. Also, the legal and ethical issues that are related to genome sequencing with the lack of the inadequate problems associated with sequencing affects the market growth of the microbiome sequencing services market.

This research report on the MEA Microbiome Sequencing Services Market has been segmented and sub-segmented into the following categories:

By Technology:

• sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Pyrosequencing
• Sanger Sequencing
• Others

By Application:

• shotgun Sequencing
• Targeted Gene Sequencing
• RNA Sequencing
• Whole Genome Sequencing
• Others

By Research Type:

• internal Research
• Outsourced Research

By Laboratory Type:

• Wet Lab
• Dry Lab

By End User:

• Pharmaceutical
• Biotechnology

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, it is a result of rising demand for next-generation sequencing services, healthcare infrastructure, and healthcare spending, the MEA is predicted to have a good proportion of the Microbiome Sequencing Services Market growth. In countries like UAE, Saudi Arabia, and South Africa, the Microbiome Sequencing Services Market is expected to show significant market growth during the anticipated period. 

South Africa microbiome sequencing services market is expected to account for the largest share of the Microbiome Sequencing Services Market during the forecast period. Raising awareness among the people about the microbiome sequencing services and the initiatives taken by the government and non-government, and the investments in the medical and healthcare sectors are expected to drive the market's growth. Furthermore, an increase in genomic research applications and expansion of microbiome sequencing are likely to fuel the rise of the microbiome sequencing services market.

KEY MARKET PLAYERS:

Leading companies leading in the MEA Microbiome sequencing services market profiled in the report are Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.